HM15211
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide)
Hanmi · Phase 1 · Completed · Enrollment 41
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Cohort 1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Cohort 2 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Cohort 3 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Cohort 4 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Cohort 5 | Obesity or overweight | n/r | n/r | n/r | n/r |